← All companies
Coverage Timeline2
Following since 2025.05- 20252025.07.013 min
The Drugmaker vs. the Platform: Novo Nordisk Dumps Hims & Hers
On the 23rd, Novo Nordisk terminated its partnership with Hims & Hers Health, citing "deceptive marketing" practices.
- 2025.05.147 min
HIMS: Blowout Q1 2025 Earnings vs. Trump's Drug Price Cuts
Hims & Hers Health, Inc. (HIMS) reported Q1 2025 revenue up 111% YoY, with subscribers and profitability surging. Meanwhile, Trump's executive orders to slash US drug prices could reshape HIMS's cost structure and competitive landscape. This analysis dives into the numbers and the policy impact.